Health Condition 1: D132- Benign neoplasm of duodenum Health Condition 2: D136- Benign neoplasm of pancreas Health Condition 3: C240- Malignant neoplasm of extrahepaticbile duct Health Condition 4: C241- Malignant neoplasm of ampulla of Vater Health Condition 5: C253- Malignant neoplasm of pancreatic duct Health Condition 6: C250- Malignant neoplasm of head of pancreas
Conditions
Interventions
Intervention1: Use of ePTFE for Pancreaticojejunostomy: Firstly, the resection part of Pancreatoduodenectomy
will be performed as per the inclusion criteria.
Following this, a duct-to-mucosa
pancreati
Sponsors
Pavithran T
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients undergoing Pancreatoduodenectomy with duct-to-mucosa Pancreaticojejunostomy 2. Benign or Malignant etiologies 3. More than or equal to 18 years of age
Exclusion criteria
Exclusion criteria: 1. Dunking type of pancreaticojejunostomy 2. Pancreaticogastrostomy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Development of Clinically Relevant Post Operative Pancreatic Fistula (type B and C) as per the ISGPS definitionTimepoint: 1 week | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Duration of stay in the intensive care unit (ICU). 2. Duration of post-operative hospital stay. 3. Reintervention 4. 30-day morbidity a. Deep/organ space infection b. Delayed gastric emptying. c. Post-pancreatomy hemorrhage. d. Other complications 5. 90 day Mortality Timepoint: 3 months | — |
Countries
India
Contacts
Public ContactDr Peeyush Varshney
All India Institute of Medical Sciences, Jodhpur
Outcome results
None listed